Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01F
- Chemical subgroupJ01FA
- Chemical substanceJ01FA15Telithromycin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
European Union
EMA · 2 registrations
Brazil
Anvisa · 1 registration
Canada
Health Canada · 1 registration
United States
FDA · 1 registration
Saudi Arabia
SFDA · 1 registration · Historical list
At a glance
- ATC code
- J01FA15
- ATC group
- Anti-infectives for systemic use
- Registers
- 4
- Historical lists
- 1
- Registrations
- 6
- With their own page
- 1
- Companies
- 5
All medicines with Telithromycin
Human medicines from every register that match Telithromycin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
25 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ketek | United States | 300MG, 400MG | tablet | Not marketed | Sanofi Aventis US |
| Azithromycin | United States | 2.5GM BASE/VIAL, 500MG BASE/VIAL | injectable | Marketed | Pharmobedient |
| Azithromycin | United States | 250MG BASE, 500MG BASE, 600MG BASE | tablet | Marketed | Bionpharma |
| Azithromycin | United States | 100MG BASE/5ML, 200MG BASE/5ML | for suspension | Marketed | Chartwell RX |
| Teva-Azithromycin | Canada | 250 MG | Tablet | Marketed | Teva Canada Limited |
| Azithromycin | Canada | 250 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Azithromycin | Canada | 250 MG | Tablet | Marketed | Sanis Health INC |
| Azithromycin | Canada | 250 MG | Tablet | Marketed | 10445517 Canada INC / North Pharmaceuticals / Dac Pharmaceuticals |
| Azithromycin | Canada | 600 MG | Tablet | Authorised | 10445517 Canada INC / North Pharmaceuticals / Dac Pharmaceuticals |
| Ketek 400MG F.C.Tablet | Saudi Arabia | Authorised | sanofi-aventis | ||
| Ketek | European Union | Withdrawn | Aventis Pharma S.A. | ||
| Levviax | European Union | Withdrawn | Aventis Pharma S.A. | ||
| Ketek | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda | ||
| Ketek | Canada | 400 MG | Tablet | Cancelled | Sanofi-Aventis Canada INC |
| Azithromycin | United States | 1% | solution | Tentative approval | Sandoz INC |
| Azithromycin | Canada | 200 MG / 5 ML | Powder For Suspension | Cancelled | Pharmascience INC |
| Azithromycin | Canada | 250 MG | Tablet | Cancelled | 4513347 Canada INC. |
| Azithromycin | Canada | 100 MG / 5 ML | Powder For Suspension | Cancelled | Dominion Pharmacal |
| Azithromycin | Canada | 600 MG | Tablet | Cancelled | Altamed Pharma |
| Azithromycin | Canada | 600 MG | Tablet | Cancelled | Sanis Health INC |
| Azithromycin | Canada | 250 MG | Tablet | Cancelled | Cobalt Pharmaceuticals Company |
| Azithromycin | Canada | 200 MG / 5 ML | Powder For Solution | Cancelled | Dominion Pharmacal |
| Azithromycin | Canada | 600 MG | Tablet | Cancelled | 4513347 Canada INC. |
| Azithromycin | Canada | 100 MG / 5 ML | Powder For Suspension | Cancelled | Pharmascience INC |
| Azithromycin | Canada | 600 MG | Tablet | Cancelled | Cobalt Pharmaceuticals Company |